Viewing Study NCT05355168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-01-22 @ 10:56 AM
Study NCT ID: NCT05355168
Status: COMPLETED
Last Update Posted: 2024-12-31
First Post: 2022-04-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma
Sponsor: Anhui Provincial Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Toxicity, Drug View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Esophageal squamous cell carcinoma View
None neoadjuvant chemoradiotherapy View
None nimotuzumab View
None camrelizumab View